Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving b-blockers plus ligation to prevent re-bleeding

Background & Aims: Pre-emptive transjugular intrahepatic portosystemic shunt (TIPS) is the treatment of choice for high -risk acute variceal bleeding (AVB; i.e., Child-Turcotte-Pugh [CTP] B8-9+active bleeding/C10-13). Nevertheless, some 'non -highrisk' patients have poor outcomes despi...

Descripción completa

Detalles Bibliográficos
Autores: Balcar, L, Mandorfer, M, Hernandez-Gea, V, Procopet, B, Meyer, EL, Giráldez, A, Amitrano, L, Villanueva, C, Thabut, D, Samaniego, LI, Silva, G Jr, Martinez, J, Genescà, J, Bureau, C, Trebicka, J, Herrera, EL, Laleman, W, Azorín, JMP, Alonso, JC, Gluud, LL, Ferreira, CN, Cañete, N, Rodríguez, M, Ferlitsch, A, Mundi, JL, Gronbæk, H, Guerra, MNH, Sassatelli, R, Dell'Era, A, Senzolo, M, Abraldes, JG, Romero-Gómez, M, Zipprich, A, Casas, M, Masnou, H, Primignani, M, Krag, A, Nevens, F, Calleja, JL, Jansen, C, Catalina, MV, Albillos, A, Rudler, M, Tapias, EA, Guardascione, MA, Tantau, M, Schwarzer, R, Reiberger, T, Laursen, SB, Lopez-Gomez, M, Cachero, A, Ferrarese, A, Ripoll, C, La Mura, V, Bosch, J, Garcia-Pagán, JC
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Institución:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Repositorio:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
OAI Identifier:oai:iibsantpau.fundanetsuite.com:p17732
Acceso en línea:https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=17732
Access Level:acceso abierto
Palabra clave:Cirrhosis
decompensation
non-selective betablocker
endoscopic variceal ligation
TIPS
Descripción
Sumario:Background & Aims: Pre-emptive transjugular intrahepatic portosystemic shunt (TIPS) is the treatment of choice for high -risk acute variceal bleeding (AVB; i.e., Child-Turcotte-Pugh [CTP] B8-9+active bleeding/C10-13). Nevertheless, some 'non -highrisk' patients have poor outcomes despite the combination of non -selective beta-blockers and endoscopic variceal ligation for secondary prophylaxis. We investigated prognostic factors for re -bleeding and mortality in 'non -high -risk' AVB to identify subgroups who may benefit from more potent treatments (i.e., TIPS) to prevent further decompensation and mortality. Methods: A total of 2,225 adults with cirrhosis and variceal bleeding were prospectively recruited at 34 centres between 20112015; for the purpose of this study, case definitions and information on prognostic indicators at index AVB and on day 5 were further refined in low -risk patients, of whom 581 (without failure to control bleeding or contraindications to TIPS) who were managed by non -selective beta-blockers/endoscopic variceal ligation, were finally included. Patients were followed for 1 year. Results: Overall, 90 patients (15%) re -bled and 70 (12%) patients died during follow-up. Using clinical routine data, no meaningful predictors of re -bleeding were identified. However, re -bleeding (included as a time -dependent co -variable) increased mortality, even after accounting for differences in patient characteristics (adjusted cause -specific hazard ratio: 2.57; 95% CI 1.434.62; p = 0.002). A nomogram including CTP, creatinine, and sodium measured at baseline accurately (concordance: 0.752) stratified the risk of death. Conclusion: The majority of 'non -high -risk' patients with AVB have an excellent prognosis, if treated according to current recommendations. However, about one -fifth of patients, i.e. those with CTP >-8 and/or high creatinine levels or hyponatremia, have a considerable risk of death within 1 year of the index bleed. Future clinical trials should investigate whether elective TIPS placement reduces mortality in these patients. (c) 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Similares en LA Referencia